The world’s biggest seller of generic drugs, Israel’s Teva Pharmaceutical Industries, cut its full-year outlook for the second time this year, blaming price pressure in its U.S. business and greater competition for its blockbuster multiple sclerosis drug.
from WSJ.com: US Business http://ift.tt/2ipVs5d
via IFTTT
No comments:
Post a Comment